Abstract
IntroductionCardiovascular magnetic resonance (CMR) and extracellular volume (ECV) mapping can quantify amyloid burden in patients with cardiac amyloidosis. At present, there is a paucity of data on tracking changes in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
